Streetbeat News

Equity Actions

CTKB

Cytek Biosciences, Inc. (NASDAQ:CTKB) has appointed William McCombe as its new CFO, effective immediately. McCombe, with a rich background in finance and leadership roles, including CFO positions at Velo3D, HZO, and Maxar Technologies, is expected to drive Cytek towards sustainable growth and long-term value creation. Cytek also reaffirmed its 2024 revenue outlook of $203M-$213M, indicating a 5% to 10% growth over 2023, with an expectation of positive net income for the year.

Portfolio Pulse from Benzinga Newsdesk

March 19, 2024 | 12:06 pm

PIXY

ShiftPixy, Inc. (NASDAQ:PIXY), a staffing enterprise for the Gig Economy, announced a $5M offering priced at-the-market under Nasdaq rules. The offering includes 1,176,470 units at $4.25 each, consisting of common stock or pre-funded warrants, and common warrants exercisable at $4.25. The proceeds are intended for general corporate purposes. A.G.P./Alliance Global Partners is the sole placement agent. The offering is expected to close on March 21, 2024.

Portfolio Pulse from Benzinga Newsdesk

March 19, 2024 | 12:04 pm

LEGN

Legend Biotech has filed for a mixed shelf offering, though the size of the offering has not been disclosed. This move allows the company flexibility in financing its operations, research, and development by issuing various types of securities over time.

Portfolio Pulse from Charles Gross

March 19, 2024 | 12:00 pm

SMCI

Super Micro Computer (SMCI) announced a proposed public offering of 2,000,000 shares of its common stock, leading to a decrease in its share price.

Portfolio Pulse from Benzinga Newsdesk

March 19, 2024 | 11:23 am

MDGL

Madrigal Pharmaceuticals announced the pricing of its upsized $600 million public offering of 750,000 shares at $260 per share, causing its stock to trade lower.

Portfolio Pulse from Benzinga Newsdesk

March 19, 2024 | 11:12 am

SMCI

Super Micro Computer, Inc. (SMCI) has announced a proposed public offering of 2 million shares of its common stock, with an option for the underwriter to purchase an additional 300,000 shares. Goldman Sachs & Co. LLC is the sole underwriter and book-running manager. The offering's completion is subject to market conditions.

Portfolio Pulse from Benzinga Newsdesk

March 19, 2024 | 11:10 am

NCMI

National CineMedia (NCMI) shares surged following the announcement of better-than-expected Q4 financial results and a new $100 million share repurchase program.

Portfolio Pulse from Benzinga Newsdesk

March 19, 2024 | 11:05 am

ACXP

Acurx Pharmaceuticals' shares are trading lower following the company's announcement of a common stock offering.

Portfolio Pulse from Benzinga Newsdesk

March 19, 2024 | 11:04 am

SMCI

Super Micro Computer has filed for a stock shelf offering, planning to offer up to 2 million shares of its common stock. This move allows the company to sell shares over time, providing flexibility in financing its operations or growth initiatives.

Portfolio Pulse from Charles Gross

March 19, 2024 | 10:54 am

CAL

CNM

CTRN

NCMI

YY

U.S. stock futures are trading lower, with focus on Core & Main, JOYY Inc., Caleres, National CineMedia, and Citi Trends due to earnings reports and corporate actions. Core & Main is expected to report earnings with a slight decrease in after-hours trading. JOYY Inc. reported strong Q4 earnings but forecasts Q1 revenues below market estimates, yet shares increased. Caleres is anticipated to report earnings with a slight rise in after-hours trading. National CineMedia reported upbeat Q4 results and announced a $100 million share repurchase program, leading to a significant share price increase. Citi Trends is expected to report earnings, with a decrease in after-hours trading.

Portfolio Pulse from Avi Kapoor

March 19, 2024 | 8:12 am